Accessibility Menu
Arrow-Thin-Down
S&P 500
6,858.47
+0.2%
+12.97
Arrow-Thin-Down
DJI
48,382.39
+0.7%
+319.10
Arrow-Thin-Down
NASDAQ
23,235.63
-0.0%
-6.36
Arrow-Thin-Down
Bitcoin
$89,927.00
+0.7%
+$598.86
Arrow-Thin-Down
UUUU
$16.61
+14.2%
+$2.07
Arrow-Thin-Down
SMR
$16.31
+15.1%
+$2.14
Arrow-Thin-Down
ADBE
$333.30
-4.8%
-$16.69
Arrow-Thin-Down
APLD
$28.06
+14.4%
+$3.54
Arrow-Thin-Down
PLTR
$167.86
-5.6%
-$9.89
Arrow-Thin-Down
ASTS
$83.47
+14.9%
+$10.84
Arrow-Thin-Down
AMZN
$226.36
-1.9%
-$4.46
Arrow-Thin-Down
GOOG
$315.32
+0.5%
+$1.52
Arrow-Thin-Down
META
$650.41
-1.5%
-$9.68
Arrow-Thin-Down
MSFT
$472.60
-2.3%
-$11.02
Arrow-Thin-Down
NVDA
$188.85
+1.3%
+$2.35
Arrow-Thin-Down
TSLA
$438.07
-2.6%
-$11.65
Daily Stock GainersDaily Stock LosersMost Active Stocks
CanSino Biologics Stock Quote

CanSino Biologics (SEHK: 6185)

$34.96
(0.1%)
+0.04
Price as of January 2, 2026, 3:08 a.m. ET

KEY DATA POINTS

Current Price
HK$34.96
Daily Change
(0.1%) +$0.04
Day's Range
HK$34.44 - HK$35.50
Previous Close
HK$34.92
Open
HK$34.80
Beta
-0.10
Volume
177,993
Average Volume
732,247
Sector
Health Care
Market Cap
$8.6B
Market Cap / Employee
$34.96M
52wk Range
HK$25.25 - HK$56.55
Revenue
N/A
Gross Margin
0.86%
Dividend Yield
N/A
EPS
-HK$0.62
CAPs Rating
N/A
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

CanSino Biologics Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
6185+11.69%-80.16%-27.6%+2%
S&P+16.87%+82.6%+12.78%+144%
Advertisement

CanSino Biologics Company Info

Chinese Vaccine producer

News & Analysis

Featured Article

Here's Your Guide to the Coronavirus Vaccine Leaders

Let's take a look at what's happened so far and what's on the horizon.

Adria Cimino  |  Jul 26, 2020
Featured Article

CanSino's COVID-19 Vaccine Was Just Approved for Limited Use in China. Here's What Investors Should Know.

Underwhelming vaccine efficacy makes for unenthusiastic stock growth.

Alex Carchidi  |  Jul 7, 2020

Financial Health

General

Q3 2025YOY Change
Revenue$338.98M18.2%
Gross Profit$265.66M34.3%
Gross Margin78.37%9.4%
Market Cap$12.24B73.7%
Market Cap / Employee$11.07M0.0%
Employees1.1K0.0%
Net Income$30.51M845.9%
EBITDA$18.37M202.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$1.18B-21.9%
Accounts Receivable$794.94M5.9%
Inventory391.12.4%

Liabilities

Q3 2025YOY Change
Long Term Debt$1.16B7.5%
Short Term Debt$398.96M-68.1%

Ratios

Q3 2025YOY Change
Return On Assets-1.82%6.3%
Return On Invested Capital-4.91%0.7%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$16,367.73K87.9%
Operating Free Cash Flow$33.79M152.7%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book1.391.581.622.2875.90%
Price to Sales8.538.818.5511.6734.42%
Price to Tangible Book Value1.471.671.722.4378.41%
Enterprise Value to EBITDA107.35-41.36-266.82603.88-287.97%
Return on Equity-7.4%-4.4%-3.3%-2.8%-78.93%
Total Debt$2.15B$2.13B$2.07B$1.56B-33.06%

No results found

No podcast episodes available.

No results found

No transcripts available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services